Trials / Active Not Recruiting
Active Not RecruitingNCT07060898
Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes
Radicle Clarity™ 25_RAM: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 650 (actual)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Active Product | Novel Nutritional Product targeting Cognition |
| DIETARY_SUPPLEMENT | Placebo Product | Identical placebo product |
Timeline
- Start date
- 2025-07-29
- Primary completion
- 2025-11-20
- Completion
- 2026-11-20
- First posted
- 2025-07-11
- Last updated
- 2026-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07060898. Inclusion in this directory is not an endorsement.